Meeting
2016 ASCO Annual Meeting
Immunotherapy (IO) versus targeted therapy triage in endometrial adenocarcinoma (EA) by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA).
Authors
Alessandro Santin
Yale School of Medicine, Orange, CT
Alessandro Santin , Kathleen N. Moore , Camille Gunderson , Kyle Gowen , David Fabrizio , Garrett Michael Frampton , Jo-Anne Vergilio , James Suh , Laurie M Gay , Shakti Ramkissoon , Siraj Mahamed Ali , Vincent A. Miller , Phil Stephens , Jeffrey S. Ross , James Sun , Julia Andrea Elvin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 5591)
DOI
10.1200/JCO.2016.34.15_suppl.5591
Abstract #
5591
Poster Bd #
414
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Genomic profiling of prostate cancer at a diverse academic center.
First Author: Robert Lopez
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2024 ASCO Annual Meeting
Comparing the somatic, germline, and immune landscapes of upper tract urothelial carcinoma (UTUC) and UC of the bladder (UCB).
First Author: Kit L. Yuen
Poster
2023 ASCO Annual Meeting
Effect of somatic-germline genomic integration on the contribution of pathogenic germline genetic variants (gPV) to colorectal cancer (CRC) carcinogenesis.
First Author: Emily Harrold